Brief: YiChang Hec Changjiang Pharmaceutical Says As At Sept 30, Loss Attributable RMB415.0 Mln
Oct 29 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* AS AT SEPT 30, LOSS ATTRIBUTABLE RMB415.0 MILLION VERSUS
PROFIT
RMB547.6 MILLION
* AS AT 30 SEPT, OPERATING REVENUE RMB449.5 MILLION
Source text for Eikon: ID:nHKS21VyWL
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million